Alto Neuroscience, Inc.'s total assets for Q1 2026 were $276.26M, an increase of 49.58% from the previous quarter. ANRO total liabilities were $32.89M for the fiscal quarter, a -1.96% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.